Abstract
Bisphosphonates are among the most widely used medicines for the treatment of bone diseases. They are generally well tolerated, serious adverse events are rare and the risk-benefit risk profile in osteoporotic patients is overwhelmingly favourable in most better option.
Cite
CITATION STYLE
APA
Ralston, S. (2015). Bisphosphonates for osteoporosis. In Medicines for Women (pp. 345–371). Springer International Publishing. https://doi.org/10.1007/978-3-319-12406-3_12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free